Haemophilus influenzae type b (Hib) polysaccharide vaccine
Trade name: Hib-Vax
Vaccineapproved
Approved
Apr 12, 1985
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1980s
- Apr 12, 1985
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Haemophilus influenzaeImmunity, active
Haemophilus influenzae immunity, active
Approval history
- approvedApr 12, 1985
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No